Renellence Confirmed as Exclusive Canadian Home for Saypha®

Toronto, Canada – January 22, 2026 – Renellence Inc. is pleased to confirm its status as the exclusive authorized distributor of Saypha® dermal fillers in Canada. Following the conclusion of Croma-Pharma’s distribution arrangement with Hugel, Renellence has assumed full responsibility for the sales, logistical support, and clinical education for the Saypha® portfolio across the country.

Renellence now assumes responsibility for the distribution and ongoing support of Saypha products in Canada, ensuring continued access for healthcare professionals and a smooth transition in service.

Saypha products now carry MDR certification with updated packaging, confirming compliance with the European Union's Medical Device Regulation, a rigorous framework ensuring safety, performance, and quality standards for medical devices across regulated markets.

To prevent any disruption in supply, current Saypha® accounts should contact Renellence immediately to update their vendor records. Our onboarding team is ready to facilitate a seamless transition for your clinic.